Introduction
Oxygen is critical to all forms of aerobic life, and imbalances of oxygen supply and consumption, such as hypoxia, are associated with disease. [1] [2] [3] [4] [5] [6] [7] For example, hypoxic and nonhypoxic tumors have different responses to therapies, and regions of hypoxic tissue can be extremely heterogenous, 8 complicating the differentiation of different types of tissues. Consequently, many visualization techniques, including optical imaging, positron emission tomography, photoacoustic imaging, and magnetic resonance imaging (MRI), are being investigated for the imaging of oxygen levels to study the progress and treatment of diseases.
9
MRI is capable of producing images of the inside of living organisms with excellent spatial resolution, and 19 F has no detectable background signal in vivo. As a result of these properties, 19 F-MRI has been used in vivo with peruorocarbon emulsions, 10 peruorocarbon nanoparticles, 11, 12 peruorocarbon-labelled cells, 13, 14 and discrete lanthanide complexes. 15 These examples of in vivo imaging with 19 F-MRI make the technique one of the most promising for noninvasive imaging, and metalbased multimodal oxygen-responsive contrast agents for 19 F-MRI would expand that promise to the imaging of hypoxiarelated diseases. The design of contrast agents for 19 F-MRI is complicated by the conict between the need for a large number of chemically equivalent uorine atoms and the hydrophobicity of uorine. Too few 19 F nuclei lead to undetectable signal, but too many 19 F nuclei are associated with low solubility. 12 Ideally, oxygen-responsive contrast agents for 19 F-MRI would be soluble in water to enable distribution in vivo and be redox-responsive to yield molecular information regarding oxidation. , one coordinated water molecule is held within the pocket formed by the p-triuoromethylbenzyl groups, effectively caging the coordinated water molecule from the surroundings. Although trapping of water has implications for T 1 -weighted MRI because impeded water exchange inuences relaxivity, 33 the pseudoaxial amides could be useful for temperature control of relaxivity. However, crystal structures describe solid-state conformations and do not account for dynamics in solution; therefore, we turned to solution-phase characterization.
To probe the stability of the pseudo-axial conformation in solution, relaxivity was measured as a function of temperature at 11.7 T between 16.5 and 40.5 C (Fig. 2 ). This temperature range was selected because it spans from slightly below room temperature to slightly above body temperature. 40 A similar, but smaller, effect in relaxivity caused by hydrophobic groups around a caged water molecule has been previously observed with a structurally similar Gd III complex that has four N-(1-phenylethyl)propionamide arms and exhibits a similar increase in relaxivity over the same temperature range. 41, 42 Additionally, the change in relaxivity is consistent with Gd III -based responsive contrast agents that modulate water coordination number.
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A possible explanation for this temperature-dependent shi in relaxivity is that thermal energy overcomes the uorous and p-stacking interactions above 24.5 C, resulting in accessibility of bulk water to participate in exchange with the coordinated water inside of the cage formed by the p-triuoromethylbenzyl arms. F-and CEST-MRI. Due to the well-behaved redox-and temperature-responsive contrast system 2Eu II/III in vitro, we investigated the behavior of the system in mice.
To verify that oxidation-state-dependent signals were observable with MRI in vivo, mice were injected in the peritoneal cavities with solutions of 2Eu II (200 mL, 5.4 mM in aqueous 3-morpholinopropane-1-sulfonic acid buffer, pH 7.0) and imaged with T 1 -weighted and 19 F-MRI scans (Fig. 4a-e) . All animal studies were done in accordance with protocols preapproved by Fig. 2 (a) Relaxation rates (11.7 T) of 2Eu II (,) (2-8 mM in aqueous 3-morpholinopropane-1-sulfonic acid buffer, pH 7.0) and 3Eu II (-) (2-15 mM in aqueous 3-morpholinopropane-1-sulfonic acid buffer, pH 7.0). Error bars represent the standard error of mean of measurements from three independently prepared samples. (b) Cartoon explanation of mechanism of temperature-dependent change in relaxivity. The coin purse represents ligand 2 that is held shut by the fluorous interactions and p-stacking at low temperatures, preventing water exchange and, consequently, inner-sphere-based contrast enhancement. As temperature increases, thermal energy overcomes the interactions, opening the ligand to enable water exchange consistent with an increase in relaxivity.
the Institutional Animal Care and Use Committee of Baylor College of Medicine. Intraperitoneal injections were selected to enable comparison with previous Eu II studies. 20 Because intraperitoneal injections in a normal mouse are in non-hypoxic conditions, it is expected that the contrast agent would lose T 1 contrast and develop 19 F signal intensity upon oxidation. T 1 -weighted MRI images of the coronal planes of mice showed contrast that appeared immediately upon injection and faded over the course of three minutes. The duration of T 1 -enhancement is consistent with intraperitoneal injection of a Eu II -containing cryptate. 20 To detect 2Eu III post-oxidation in vivo, we collected 19 F spectra of mice between T 1 -weighted scans.
19 F signal intensity appeared nine minutes post injection (Fig. 4i) II (3.5 mM); and (d) 2Eu III after oxidation of 2Eu II (3.5 mM). 19 F-MRI images of (e) 3-morpholinopropane-1-sulfonic acid (20 mM, pH 7.0); (f) 2Eu III (3.5 mM); (g) 2Eu II (3.5 mM); and (h) 2Eu III after oxidation of 2Eu II (3.5 mM). The scale bar on the right of (h) represents signal intensity for all 19 F-MRI images in Fig. 3 . CEST MRI images of (i) 3-morpholinopropane-1-sulfonic acid (20 mM, pH 7.0); (j) 2Eu III (3.5 mM); (k) 2Eu II (3.5 mM); and (l) 2Eu III after oxidation of 2Eu II (3.5 mM). The scale bar on the right of (l) represents signal intensity for all CEST MRI images in Fig. 3 . 
Conclusions
In conclusion, we have synthesized a new redox-active contrast agent, 2Eu II/III , that also displays temperature-dependent relaxivity, which was used as a tool for probing mechanism. The intramolecular uorous interactions among p-triuoromethylbenzylamides lead to the formation of a cage-like structure that modulates the interactions of water with Eu as a function of temperature, evidenced by the change in relaxivity.
Because of the presence of uorine atoms and amide protons, the system can be tracked in vivo aer oxidation with a variety of instruments that are equipped with either CEST or 19 F-MR imaging capabilities. We also observed intact complex in mouse urine post-injection, which is promising for future toxicity studies and in vivo imaging. Together, our results allude to a new molecular strategy for rationally designing ligand architectures by modulating interactions between Eu II and water with intramolecular uorous attractions. These results could pave the way to using existing imaging techniques with new chemical agents to access previously unattainable oxidative information noninvasively in vivo.
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